InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Prince Joshua S.. Officer active across 1 company, notably VistaGen Therapeutics, Inc.. Cumulatively, 2 reports have been published. History available since 28 June 2024. The latest transaction was filed on 31 December 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations